CCRF Consulting Co., Ltd.   Report issue

For profit Phase 4
Founded: Beijing China (2009)

Organization Overview

First Clinical Trial
2010
NCT01157455
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CCRF Inc., Beijing, China

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 4)

Coronary Disease (Phase 4)

Myocardial Ischemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 5